Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

被引：108

作者：

Goyal, Lipika ^{[1
]}

Govindan, Aparna ^{[1
]}

Sheth, Rahul A. ^{[1
]}

Nardi, Valentina ^{[1
]}

Blaszkowsky, Lawrence S. ^{[1
]}

Faris, Jason E. ^{[1
]}

Clark, Jeffrey W. ^{[1
]}

Ryan, David P. ^{[1
]}

Kwak, Eunice L. ^{[1
]}

Allen, Jill N. ^{[1
]}

Murphy, Janet E. ^{[1
]}

Saha, Supriya K. ^{[1
]}

Hong, Theodore S. ^{[1
]}

Wo, Jennifer Y. ^{[1
]}

Ferrone, Cristina R. ^{[1
]}

Tanabe, Kenneth K. ^{[1
]}

Chong, Dawn Q. ^{[1
]}

Deshpande, Vikram ^{[1
]}

Borger, Darrell R. ^{[1
]}

Iafrate, A. John ^{[1
]}

Bardeesy, Nabeel ^{[1
]}

Zheng, Hui ^{[1
]}

Zhu, Andrew X. ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA

来源：

ONCOLOGIST | 2015年 / 20卷 / 09期

关键词：

Cholangiocarcinoma; Isocitrate dehydrogenase; Prognosis; Metastatic; Phenotype; PRIMARY SCLEROSING CHOLANGITIS; ACUTE MYELOID-LEUKEMIA; BILIARY-TRACT CANCER; ONCOMETABOLITE; 2-HYDROXYGLUTARATE; MUTATIONS; LEWIS; DIFFERENTIATION; CA19-9; CHEMOTHERAPY; BIOMARKER;

D O I：

10.1634/theoncologist.2015-0210

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background. Conflicting data exist regarding the prognostic impact of the isocitrate dehydrogenase (IDH) mutation in intrahepatic cholangiocarcinoma (ICC), and limited data exist in patients with advanced-stage disease. Similarly, the clinical phenotype of patients with advanced IDH mutant (IDHm) ICC has not been characterized. In this study, we report the correlation of IDH mutation status with prognosis and clinicopathologic features in patients with advanced ICC. Methods. Patients with histologically confirmed advanced ICC who underwent tumor mutational profiling as a routine part of their care between 2009 and 2014 were evaluated. Clinical and pathological data were collected by retrospective chart review for patients with IDHm versus IDH wild-type (IDHwt) ICC. Pretreatment tumor volume was calculated on computed tomography or magnetic resonance imaging. Results. Of the 104 patients with ICC who were evaluated, 30 (28.8%) had an IDH mutation (25.0% IDH1, 3.8% IDH2). The median overall survival did not differ significantly between IDHm and IDHwt patients (15.0 vs. 20.1 months, respectively; p = .17). The pretreatment serum carbohydrate antigen 19-9 (CA19-9) level in IDHm and IDHwt patients was 34.5 and 118.0 U/mL, respectively (p = .04). Age at diagnosis, sex, histologic grade, and pattern of metastasis did not differ significantly by IDH mutation status. Conclusion. The IDH mutation was not associated with prognosis in patients with advanced ICC. The clinical phenotypes of advanced IDHm and IDHwt ICC were similar, but patients with IDHm ICC had a lower median serum CA19-9 level at presentation.

引用

页码：1019 / 1027

页数：9

共 40 条

[1] Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma [J].

Borger, Darrell R. ;

Goyal, Lipika ;

Yau, Thomas ;

Poon, Ronnie T. ;

Ancukiewicz, Marek ;

Deshpande, Vikram ;

Christiani, David C. ;

Liebman, Hannah M. ;

Yang, Hua ;

Kim, Hyeryun ;

Yen, Katharine ;

Faris, Jason E. ;

Iafrate, A. John ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Allen, Jill N. ;

Blaszkowsky, Lawrence S. ;

Murphy, Janet E. ;

Saha, Supriya K. ;

Hong, Theodore S. ;

Wo, Jennifer Y. ;

Ferrone, Cristina R. ;

Tanabe, Kenneth K. ;

Bardeesy, Nabeel ;

Straley, Kimberly S. ;

Agresta, Sam ;

Schenkein, David P. ;

Ellisen, Leif W. ;

Ryan, David P. ;

Zhu, Andrew X. .

CLINICAL CANCER RESEARCH, 2014, 20 (07) :1884-1890

[2] Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping [J].

Borger, Darrell R. ;

Tanabe, Kenneth K. ;

Fan, Kenneth C. ;

Lopez, Hector U. ;

Fantin, Valeria R. ;

Straley, Kimberly S. ;

Schenkein, David P. ;

Hezel, Aram F. ;

Ancukiewicz, Marek ;

Liebman, Hannah M. ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Ryan, David P. ;

Deshpande, Vikram ;

Dias-Santagata, Dora ;

Ellisen, Leif W. ;

Zhu, Andrew X. ;

Iafrate, A. John .

ONCOLOGIST, 2012, 17 (01) :72-79

[3] Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study [J].

Chalasani, N ;

Baluyut, A ;

Ismail, A ;

Zaman, A ;

Sood, G ;

Ghalib, R ;

McCashland, TM ;

Reddy, KR ;

Zervos, X ;

Anbari, MA ;

Hoen, H .

HEPATOLOGY, 2000, 31 (01) :7-11

[4] Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine [J].

Dias-Santagata, Dora ;

Akhavanfard, Sara ;

David, Serena S. ;

Vernovsky, Kathy ;

Kuhlmann, Georgiana ;

Boisvert, Susan L. ;

Stubbs, Hannah ;

McDermott, Ultan ;

Settleman, Jeffrey ;

Kwak, Eunice L. ;

Clark, Jeffrey W. ;

Isakoff, Steven J. ;

Sequist, Lecia V. ;

Engelman, Jeffrey A. ;

Lynch, Thomas J. ;

Haber, Daniel A. ;

Louis, David N. ;

Ellisen, Leif W. ;

Borger, Darrell R. ;

Lafrate, A. John .

EMBO MOLECULAR MEDICINE, 2010, 2 (05) :146-158

[5] Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].

Figueroa, Maria E. ;

Abdel-Wahab, Omar ;

Lu, Chao ;

Ward, Patrick S. ;

Patel, Jay ;

Shih, Alan ;

Li, Yushan ;

Bhagwat, Neha ;

Vasanthakumar, Aparna ;

Fernandez, Hugo F. ;

Tallman, Martin S. ;

Sun, Zhuoxin ;

Wolniak, Kristy ;

Peeters, Justine K. ;

Liu, Wei ;

Choe, Sung E. ;

Fantin, Valeria R. ;

Paietta, Elisabeth ;

Lowenberg, Bob ;

Licht, Jonathan D. ;

Godley, Lucy A. ;

Delwel, Ruud ;

Valk, Peter J. M. ;

Thompson, Craig B. ;

Levine, Ross L. ;

Melnick, An .

CANCER CELL, 2010, 18 (06) :553-567

[6] Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing [J].

Frampton, Garrett M. ;

Fichtenholtz, Alex ;

Otto, Geoff A. ;

Wang, Kai ;

Downing, Sean R. ;

He, Jie ;

Schnall-Levin, Michael ;

White, Jared ;

Sanford, Eric M. ;

An, Peter ;

Sun, James ;

Juhn, Frank ;

Brennan, Kristina ;

Iwanik, Kiel ;

Maillet, Ashley ;

Buell, Jamie ;

White, Emily ;

Zhao, Mandy ;

Balasubramanian, Sohail ;

Terzic, Selmira ;

Richards, Tina ;

Banning, Vera ;

Garcia, Lazaro ;

Mahoney, Kristen ;

Zwirko, Zac ;

Donahue, Amy ;

Beltran, Himisha ;

Mosquera, Juan Miguel ;

Rubin, Mark A. ;

Dogan, Snjezana ;

Hedvat, Cyrus V. ;

Berger, Michael F. ;

Pusztai, Lajos ;

Lechner, Matthias ;

Boshoff, Chris ;

Jarosz, Mirna ;

Vietz, Christine ;

Parker, Alex ;

Miller, Vincent A. ;

Ross, Jeffrey S. ;

Curran, John ;

Cronin, Maureen T. ;

Stephens, Philip J. ;

Lipson, Doron ;

Yelensky, Roman .

NATURE BIOTECHNOLOGY, 2013, 31 (11) :1023-+

[7] Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas [J].

Jiao, Yuchen ;

Pawlik, Timothy M. ;

Anders, Robert A. ;

Selaru, Florin M. ;

Streppel, Mirte M. ;

Lucas, Donald J. ;

Niknafs, Noushin ;

Guthrie, Violeta Beleva ;

Maitra, Anirban ;

Argani, Pedram ;

Offerhaus, G. Johan A. ;

Roa, Juan Carlos ;

Roberts, Lewis R. ;

Gores, Gregory J. ;

Popescu, Irinel ;

Alexandrescu, Sorin T. ;

Dima, Simona ;

Fassan, Matteo ;

Simbolo, Michele ;

Mafficini, Andrea ;

Capelli, Paola ;

Lawlor, Rita T. ;

Ruzzenente, Andrea ;

Guglielmi, Alfredo ;

Tortora, Giampaolo ;

de Braud, Filippo ;

Scarpa, Aldo ;

Jarnagin, William ;

Klimstra, David ;

Karchin, Rachel ;

Velculescu, Victor E. ;

Hruban, Ralph H. ;

Vogelstein, Bert ;

Kinzler, Kenneth W. ;

Papadopoulos, Nickolas ;

Wood, Laura D. .

NATURE GENETICS, 2013, 45 (12) :1470-U93

[8] 2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP+-Dependent Isocitrate Dehydrogenase Mutations [J].

Jin, Genglin ;

Reitman, Zachary J. ;

Spasojevic, Ivan ;

Batinic-Haberle, Ines ;

Yang, Jian ;

Schmidt-Kittler, Oleg ;

Bigner, Darell D. ;

Yan, Hai .

PLOS ONE, 2011, 6 (02)

[9]

Kim HJ, 1999, AM J GASTROENTEROL, V94, P1941

[10] Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma [J].

Kipp, Benjamin R. ;

Voss, Jesse S. ;

Kerr, Sarah E. ;

Fritcher, Emily G. Barr ;

Graham, Rondell P. ;

Zhang, Lizhi ;

Highsmith, W. Edward ;

Zhang, Jun ;

Roberts, Lewis R. ;

Gores, Gregory J. ;

Halling, Kevin C. .

HUMAN PATHOLOGY, 2012, 43 (10) :1552-1558

← 1 2 3 4 →